Estimation using all available covariate information versus a fixed look-back window for dichotomous covariates.

PubWeight™: 1.15‹?› | Rank: Top 10%

🔗 View Article (PMC 3653131)

Published in Pharmacoepidemiol Drug Saf on March 22, 2013

Authors

Steven M Brunelli1, Joshua J Gagne, Krista F Huybrechts, Shirley V Wang, Amanda R Patrick, Kenneth J Rothman, John D Seeger

Author Affiliations

1: Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02120, USA. sbrunelli@partners.org

Articles citing this

The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol (2015) 3.29

Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis. J Am Coll Cardiol (2016) 1.41

Distinguishing incident and prevalent diabetes in an electronic medical records database. Pharmacoepidemiol Drug Saf (2013) 0.93

Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study. Drug Saf (2015) 0.89

Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform. J Am Soc Nephrol (2016) 0.86

Misclassification in administrative claims data: quantifying the impact on treatment effect estimates. Curr Epidemiol Rep (2014) 0.84

Revisiting the washout period in the incident user study design: why 6-12 months may not be sufficient. J Comp Eff Res (2015) 0.84

Thienopyridine use after coronary stenting in low income patients enrolled in medicare part D receiving maintenance dialysis. J Am Heart Assoc (2014) 0.82

Incidence of opioid-managed pelvic pain after hysteroscopic sterilization versus laparoscopic sterilization, US 2005-2012. Pharmacoepidemiol Drug Saf (2015) 0.80

Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors. Stroke (2015) 0.80

Patterns of Lipid Lowering Therapy among Children Ages 8-20 Years. J Pediatr (2015) 0.79

Fracture rate associated with quality metric-based anti-osteoporosis treatment in glucocorticoid-induced osteoporosis. Osteoporos Int (2015) 0.77

Optimal Use of Available Claims to Identify a Medicare Population Free of Coronary Heart Disease. Am J Epidemiol (2015) 0.76

Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study. BMJ Open (2017) 0.75

Cohort restriction based on prior enrollment: Examining potential biases in estimating cancer and mortality risk. Obs Stud (2016) 0.75

Treatment of atrial fibrillation with warfarin among older adults with end stage renal disease. J Nephrol (2017) 0.75

Articles cited by this

The accuracy of Medicare's hospital claims data: progress has been made, but problems remain. Am J Public Health (1992) 6.97

The effect of misclassification in the presence of covariates. Am J Epidemiol (1980) 5.66

Selection of controls in case-control studies. I. Principles. Am J Epidemiol (1992) 3.94

Differential misclassification arising from nondifferential errors in exposure measurement. Am J Epidemiol (1991) 2.85

Bias from nondifferential but dependent misclassification of exposure and outcome. Epidemiology (1992) 2.11

Insurance or a regular physician: which is the most powerful predictor of health care? Am J Public Health (1998) 1.97

Estimating and correcting for confounder misclassification. Am J Epidemiol (1989) 1.80

Varied forms of bias due to nondifferential error in measuring exposure. Epidemiology (1994) 1.29

Correlated nondifferential misclassifications of disease and exposure: application to a cross-sectional study of the relation between handedness and immune disorders. Int J Epidemiol (1992) 1.07

Comparing the effects of continuous and discrete covariate mismeasurement, with emphasis on the dichotomization of mismeasured predictors. Biometrics (2002) 1.06

Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin. J Gen Intern Med (2005) 0.99

Women living with substance abuse and HIV disease: medical care access issues. J Am Med Womens Assoc (1995) 0.96

Determining the test characteristics of claims-based diagnostic codes for the diagnosis of venous thromboembolism in a medical service claims database. Pharmacoepidemiol Drug Saf (2010) 0.93

Misclassification of covariates. Stat Med (1991) 0.83

Articles by these authors

Variable selection for propensity score models. Am J Epidemiol (2006) 10.68

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet (2002) 9.66

A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol (2005) 7.31

The rise and fall of epidemiology, 1950-2000 A.D. 1981. Int J Epidemiol (2007) 4.56

Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States. BMJ (2013) 3.88

Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA (2010) 3.85

Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol (2007) 3.82

Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol (2005) 3.33

Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clin Infect Dis (2008) 3.09

Outcomes of neonates undergoing extracorporeal membrane oxygenation support using centrifugal versus roller blood pumps. Ann Thorac Surg (2012) 2.97

The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int (2004) 2.88

Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study. Am J Epidemiol (2010) 2.74

Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide. Curr Med Res Opin (2009) 2.68

Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstet Gynecol (2014) 2.67

Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis (2005) 2.65

The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol (2011) 2.61

Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med (2008) 2.59

Performance of propensity score calibration--a simulation study. Am J Epidemiol (2007) 2.56

Statin adherence and risk of accidents: a cautionary tale. Circulation (2009) 2.47

Exploring relative mortality and epoetin alfa dose among hemodialysis patients. Am J Kidney Dis (2008) 2.43

Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries. Circulation (2008) 2.42

Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile. Pharmacoepidemiol Drug Saf (2006) 2.38

Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care (2007) 2.31

Patterns of second-line uterotonic use in a large sample of hospitalizations for childbirth in the United States: 2007-2011. Anesth Analg (2014) 2.04

Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs. Pharmacoepidemiol Drug Saf (2013) 2.01

The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis. Epidemiology (2011) 2.01

Insights into different results from different causal contrasts in the presence of effect-measure modification. Pharmacoepidemiol Drug Saf (2006) 1.99

The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits. Health Aff (Millwood) (2009) 1.95

Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial. Arch Intern Med (2012) 1.94

Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev (2007) 1.94

Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis (2011) 1.92

Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies. Hepatology (2006) 1.87

Seasonal variation in hospital discharge diagnosis of atrial fibrillation: a population-based study. Epidemiology (2002) 1.85

One-to-many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf (2012) 1.82

Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study. Ann Intern Med (2014) 1.78

Effects of adjusting for instrumental variables on bias and precision of effect estimates. Am J Epidemiol (2011) 1.77

Effect of obesity on the outcome of kidney transplantation: a 20-year follow-up. Transplantation (2011) 1.77

Harnessing the Medicaid Analytic eXtract (MAX) to Evaluate Medications in Pregnancy: Design Considerations. PLoS One (2013) 1.74

Healthy user and related biases in observational studies of preventive interventions: a primer for physicians. J Gen Intern Med (2011) 1.74

The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration. Pharmacoepidemiol Drug Saf (2011) 1.74

Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment. Circulation (2007) 1.72

Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy. Am J Epidemiol (2012) 1.68

Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis. Drugs (2010) 1.67

Development of a comorbidity index for use in obstetric patients. Obstet Gynecol (2013) 1.65

Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study. BMJ (2011) 1.65

An internet-based prospective study of body size and time-to-pregnancy. Hum Reprod (2009) 1.64

The risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy. Pharmacoepidemiol Drug Saf (2007) 1.64

Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use. Arch Intern Med (2007) 1.62

Cohort profile: the Danish Web-based Pregnancy Planning Study--'Snart-Gravid'. Int J Epidemiol (2008) 1.62

Gaps in treatment among users of osteoporosis medications: the dynamics of noncompliance. Am J Med (2007) 1.62

Impact of baseline heart failure burden on post-implantable cardioverter-defibrillator mortality among medicare beneficiaries. J Am Coll Cardiol (2013) 1.62

The effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey. Pharmacoepidemiol Drug Saf (2013) 1.61

Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting. Clin Infect Dis (2008) 1.60

A prospective cohort study of physical activity and time to pregnancy. Fertil Steril (2012) 1.58

Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study. BMJ (2013) 1.58

A successful implementation of e-epidemiology: the Danish pregnancy planning study 'Snart-Gravid'. Eur J Epidemiol (2010) 1.57

Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information. Med Care (2007) 1.56

The cost-effectiveness of C-reactive protein testing and rosuvastatin treatment for patients with normal cholesterol levels. J Am Coll Cardiol (2011) 1.55

Topiramate use in pregnancy and the birth prevalence of oral clefts. Pharmacoepidemiol Drug Saf (2014) 1.52

Antidepressants and breast and ovarian cancer risk: a review of the literature and researchers' financial associations with industry. PLoS One (2011) 1.50

Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border. Environ Health Perspect (2006) 1.47

Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data. Arch Gen Psychiatry (2010) 1.43

Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants? Am J Epidemiol (2012) 1.43

Does relaxed reproductive selection explain the decline in male reproductive health? A new hypothesis. Epidemiology (2002) 1.42

Cost of managing complications resulting from type 2 diabetes mellitus in Canada. BMC Health Serv Res (2003) 1.42

Responses to "Texaco and its consultants": elevating the level of scientific discourse. Int J Occup Environ Health (2005) 1.41

The effect of transitioning to medicare part d drug coverage in seniors dually eligible for medicare and medicaid. J Am Geriatr Soc (2008) 1.41

Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts. Pediatrics (2010) 1.40

Effect of aprotinin on renal dysfunction. Lancet (2008) 1.39

Using prescription claims data for drugs available over-the-counter (OTC). Pharmacoepidemiol Drug Saf (2007) 1.39

Extra scrutiny for industry funded trials. BMJ (2005) 1.38

Consistent control of mineral and bone disorder in incident hemodialysis patients. Clin J Am Soc Nephrol (2008) 1.36

Update on unethical use of placebos in randomised trials. Bioethics (2003) 1.35

Screening for prostate cancer remains controversial. BMJ (2009) 1.34

Role of disease risk scores in comparative effectiveness research with emerging therapies. Pharmacoepidemiol Drug Saf (2012) 1.32

Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study. Circulation (2002) 1.32

Confounder summary scores when comparing the effects of multiple drug exposures. Pharmacoepidemiol Drug Saf (2010) 1.31

Obesity and mortality risk among younger dialysis patients. Clin J Am Soc Nephrol (2012) 1.29

Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States. Pediatrics (2010) 1.29

Cost of managing an episode of relapse in multiple sclerosis in the United States. BMC Health Serv Res (2003) 1.27

Randomized trial of questionnaire length. Epidemiology (2009) 1.27

Prescription drug insurance coverage and patient health outcomes: a systematic review. Am J Public Health (2015) 1.27

Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes. CMAJ (2011) 1.26

Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes (2012) 1.26

Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States. Anesthesiology (2014) 1.24

Confounding adjustment in comparative effectiveness research conducted within distributed research networks. Med Care (2013) 1.23

Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol (2006) 1.21

Age dependence of the relation between reassortant rotavirus vaccine (RotaShield) and intussusception. J Infect Dis (2006) 1.21

Availability of comparative efficacy data at the time of drug approval in the United States. JAMA (2011) 1.21

The comparative safety of rosuvastatin: a retrospective matched cohort study in over 48,000 initiators of statin therapy. Pharmacoepidemiol Drug Saf (2006) 1.20

Validity of maternal and infant outcomes within nationwide Medicaid data. Pharmacoepidemiol Drug Saf (2014) 1.19

Incidence of allergic reactions associated with antibacterial use in a large, managed care organisation. Drug Saf (2007) 1.18

Lipid profiles among US elderly with untreated rheumatoid arthritis--the Third National Health and Nutrition Examination Survey. J Rheumatol (2005) 1.16

Association of Apgar score at five minutes with long-term neurologic disability and cognitive function in a prevalence study of Danish conscripts. BMC Pregnancy Childbirth (2009) 1.15